Yoshiaki Tsuyuki
A5088920198- Venous Thromboembolism Diagnosis and Management
- Atrial Fibrillation Management and Outcomes
- Central Venous Catheters and Hemodialysis
- Diagnosis and Treatment of Venous Diseases
- Acute Myocardial Infarction Research
- Acute Ischemic Stroke Management
- Blood Coagulation and Thrombosis Mechanisms
- Cardiac tumors and thrombi
- Blood Pressure and Hypertension Studies
- Eosinophilic Disorders and Syndromes
- Antiplatelet Therapy and Cardiovascular Diseases
- Inflammatory Biomarkers in Disease Prognosis
- Meta-analysis and systematic reviews
- Radiation Dose and Imaging
- Neuroscience of respiration and sleep
- Ultrasound in Clinical Applications
- Cardiac, Anesthesia and Surgical Outcomes
- Pulmonary Hypertension Research and Treatments
- Peripheral Artery Disease Management
- Traumatic Brain Injury and Neurovascular Disturbances
- Cardiac Imaging and Diagnostics
- Hospital Admissions and Outcomes
- Neonatal and fetal brain pathology
- Heart Rate Variability and Autonomic Control
- Aortic aneurysm repair treatments
Shimada Municipal Hospital
2018-2024
RELX Group (United States)
2020
Juntendo University
2014
Background:Venous thromboembolism (VTE) has a long-term risk of recurrence, which can be prevented by anticoagulation therapy.
There is a paucity of data on the management and prognosis cancer-associated venous thromboembolism (VTE), leading to uncertainty about optimal strategies.Methods Results:The COMMAND VTE Registry multicenter registry enrolling 3,027 consecutive acute symptomatic patients in Japan between 2010 2014. We divided entire cohort into 3 groups: active cancer (n=695, 23%), history (n=243, 8%), no (n=2089, 69%). The rate anticoagulation discontinuation was higher with (43.5%, 27.0%, respectively, at...
Background: The simplified pulmonary embolism severity index (sPESI) score has been reported to be useful in predicting 30-day mortality for patients with embolism, which helps the identification of low-risk early hospital discharge or home treatment. However, therapeutic decision-making should also based on risks adverse events other than mortality. Methods: COMMAND VTE Registry is a multicentre registry enrolling consecutive acute symptomatic venous thromboembolism Japan between January...
Background Real-world data on clinical characteristics and outcomes related to the use of different direct oral anticoagulants (DOACs) for cancer-associated venous thromboembolism (VTE) is lacking. Methods The COMMAND VTE Registry-2 a multicenter registry enrolling 5,197 consecutive patients with acute symptomatic from 31 centers in Japan January 2015 August 2020. Our study population comprised 1,197 active cancer who were divided into edoxaban (N = 643, 54%), rivaroxaban 297, 25%), apixaban...
It remains controversial whether sex category is a risk for recurrent venous thromboembolism (VTE) and major bleeding among VTE patients.
Background There are limited data assessing the risk for bleeding on anticoagulation therapy beyond acute phase in patients with venous thromboembolism (VTE). The present study aimed to identify factors major during prolonged VTE patients. Patients and Methods COMMAND Registry is a multicenter registry enrolling 3,027 consecutive symptomatic VTE. current population consisted of 2,728 who received phase, after excluding those events (n = 48), death 66), or loss follow-up 32) initial...
Background Chronic thromboembolic pulmonary hypertension (CTEPH) is a life‐threatening complication post‐acute embolism (PE). The assessment of CTEPH incidence and risk factors PE in the era direct oral anticoagulants remains insufficient. Methods Results COMMAND VTE Registry‐2 (contemporary management outcomes patients with venous thromboembolism registry‐2) multicenter registry that recruited consecutive acute symptomatic from 31 centers across Japan. primary outcome was to demonstrate...
Idiopathic inflammatory myopathies, such as dermatomyositis, are implicated possible risk factors for venous thromboembolism. We herein report the first known case of a 50-year-old woman who presented to our hospital with fever, chest pain, and elevated creatine kinase levels was ultimately diagnosed pulmonary embolism anti-OJ antibody-positive antisynthetase myopathy. Dermatomyositis may increase thromboembolism, including embolism. However, only few cases developing before diagnosis...
Patients with cancer-associated venous thromboembolism (VTE) are at high risk for recurrent VTE and recommended to receive prolonged anticoagulation therapy if they a low bleeding. However, there no established factors bleeding during therapy.
Objectives: Factor(s) affecting the sac size of an abdominal aortic aneurysm (AAA) after endovascular repair (EVAR) remain unclear. We compared diameter at one year surgery with preoperative using CT images.Methods: Patients who underwent EVAR Juntendo University Hospital were involved. According to change in treated lesions aorta, patients categorized into following 3 groups: shrink (<5 mm reduction), enlarge (>5 expansion), and no (size within 5 mm). The patients’ background, laboratory...